21 May 2009
Improving the function of the kidney graft by verapamil– does it depend on metabolic or haemodynamic effect?
M Nowacki, M Droździk, K Ciechanowski, L Domański, K Safranof, Z Zietek, J Sienko, M Romanowski, T Sulikowski, M Kaminski, K Pabisiak, M OstrowskiAnn Transplant 2009; 14(1): 58-58 :: ID: 880412
Abstract
The aim of this study was to evaluate influence of Verapamil on the function of the transplanted kidney three months after transplantation and influence of changing vessel resistance by Verapamil on the functioning transplanted kidney.
Material/Methods: 48 cadaver kidney donors and 96 transplanted patients. The analysed group was 48 kidneys that received injection of 100 μg of Verapamil directly into renal artery 2 minutes before beginning perfusion. The control group was 48 kidneys from the same pair without pre-conditioning with Verapamil.
Results: The level of kidneys' perfusion after adding Verapamil was significantly higher comparing to perfusion of kidneys without adding Verapamil (SD 161 ml/min vs. 111 ml/min). Recipients from the group, that received kidneys after adding Verapamil reached faster the level of 2.0 mg/dL of serum creatinine than recipients from the control group (p<0.005). Level of perfusion did not influence reaching 2.0 mg/dL serum creatinine level in both groups of recipients (p<0.05)
Conclusions: We noticed that Verapamil improves the kidney graft function in the first three months after transplantation. Verapamil reduces kidney's vessel resistance but it does not correlate with improving the function of the kidney after transplantation, however this effect could depend on metabolic effect [blocking calcium channels].
Keywords: Ischemia reperfusion injury, Kidney Transplantation, Organ Perfusion
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






